|
25th Anniversary Pharmaceutical & Medical Device Ethics and Compliance Congress Features MIT McArthur Genius Award Winner on AI and Life Sciences
|
- Special Early/Early Bird Ends 7/12
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- Media Partner: Policy & Medicine
- October 28-30, 2024
- Grand Hyatt Washington
- Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
JOIN US TO CELEBRATE 25 YEARS OF COLLABORATION AMONG INDUSTRY, GOVERNMENT AND INDUSTRY PARTNERS TO PROMOTE ETHICS AND COMPLIANCE IN THE PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
|
FOR THE FIRST TIME ALL ONSITE ATTENDEES WILL ALSO HAVE ACCESS TO THE CONGRESS LIVE AND ARCHIVED VIRTUAL BROADCAST
|
|
FEATURING THE IMPLICATIONS OF AI FOR LIFE SCIENCES BY
|
|

Regina Barzilay, PhD
School of Engineering Distinguished Professor for AI and Health, MIT Center for Machine Learning in Health; AI Faculty Lead, Jameel Clinic, MIT Computer Science & Artificial Intelligence Lab; Recipient, MacArthur Genius Fellowship, NSF Career Award, and AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity, Cambridge, MA |
|
SPECIAL 25TH ANNIVERSARY EARLY/EARLY BIRD REGISTRATION DISCOUNT FOR BOTH INDIVIDUALS AND GROUPS
|
Click here to register by July 12.
|
|
SPECIAL EARLY GROUP REGISTRATION DISCOUNT EXCLUSIVELY FOR PCF MEMBERS
|
Click here for group registration discounts.
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 19, 2024: We are pleased to announce that the Twenty-Fifth Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Grand Hyatt Washington, Washington, DC on October 28-30, 2024. Attendees may attend either virtually online or in person. For the first time, onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
KEYNOTE SPEAKERS
|

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD |

Joshua S. Levy, JD
Acting United States Attorney; Former Assistant United States Attorney, District of Massachusetts, US Department of Justice, Boston, MA |

Regina Barzilay, PhD
School of Engineering Distinguished Professor for AI and Health, MIT Center for Machine Learning in Health; AI Faculty Lead, Jameel Clinic, MIT Computer Science & Artificial Intelligence Lab; Recipient, MacArthur Genius Fellowship, Cambridge, MA
|

Susan Dentzer
President and Chief Executive Officer, America's Physician Groups; Wrote and Hosted PBS documentary, Reinventing American Healthcare; Former Editor in Chief, Health Affairs; Former Health Correspondent, PBS NewsHour, Washington, DC |

Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & Univ of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA |

Brent Saunders, MBA, JD
Chairman & Chief Executive Officer, Bausch + Lomb; Former Chair, President & CEO, Allergan; President & CEO, Actavis plc; President & CEO, Forest Laboratories; President, Global Consumer Healthcare; Schering-Plough; Co-founder, International Association of Privacy Professionals (IAPP) and Pharmaceutical Compliance Forum (PCF), Miami Beach, FL
|
|
ANNUAL UPDATES FROM ADVAMeD, PhRMA AND BIO
|

John Delacourt, JD
Deputy General Counsel, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, Federal Trade Commission, Washington, DC |

Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC |

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
FEATURED FACULTY
|

David Amendola
Director, Resolution Economics; Former, Global Compliance Risk Evaluation and Management, ConvaTec, New York, NY |

Samantha Barrett Badlan, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC |

Yogesh Bahl, MBA
Partner & Leader, Life Sciences & Healthcare Practice, Resolution Economics; CFO & Head Investor Relations, IACTA Pharma, New York, NY
|

Eric M. Baim
Partner Dovetail; Former VP, Head of Compliance, US, Shire; Former Executive Director, Global Integrity & Compliance, Novartis, Boston, MA |

Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding, Washington, DC |

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Durham, NC
|

Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx; Former Director, Corporate Compliance, Kaleo, San Francisco, CA |

Jennifer Bragg, JD
Partner, Latham & Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |

Alfred R. Brunetti, JD
Principal, Porzio, Bromberg & Newman; Former Assistant Prosecutor, Union County Prosecutor's Office, Morristown, NJ
|

Parth Chanda, MPA, JD
Founder & CEO, Lextegrity; Former Chief Compliance Counsel - Global Oncology, Pfizer, New York, NY |

Andrew Clark, MBA
Partner/Principal, Forensic & Integrity Services, EY, Washington, DC |

Chris Cobourn, MS
Managing Director GP Practice Lead, Helio, Placida, FL
|

Patricia Cone, PhD
Director, Compliance (R&D, Medical Affairs), Boehringer Ingelheim; Former Head, Global R&D Compliance, Takeda, Ridgefield, CN |

BJ D'Avella, MBA
Group Leader, Life Sciences Consulting Group, Paul Hastings, New York, NY |

Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL
|

Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC |

Adriana Davies, JSM
VP, Compliance & Data Privacy, Smith & Nephew; Former Senior Compliance Director MITG, Medtronic, Jacksonville, FL |

James M. Dawson
VP, Compliance Solutions, Qordata; Former VP & CCO, United Therapeutics; Former VP, Global Compliance Officer, Consumer Healthcare, GSK, Carrboro, NC
|

Gregory Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, HHS Office of Inspector General, Washington, DC |

Sarah diFrancesca, JD
Executive Director Compliance, Dermatology, Incyte, Chadds Ford, PA |

Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC
|

Avia M. Dunn, JD, MBA
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meagher & Flom, Washington, DC |

Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY |

Jacob T. Elberg, JD
Associate Professor & Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney's Office, District of New Jersey, Newark, NJ
|

Andrea Falcione, JD, CCEP
Chief Ethics & Compliance Officer & Head of Advisory Services, Rethink Compliance, Boston, MA |

Margaret K. Feltz, MA, JD
Vice President, Ethics & Compliance, CCO, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CN |

David Fisher, MS
President & Chief Operating Officer, TD International, Washington, DC
|

Maya P. Florence, JD
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meager & Flom, Boston, MA |

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC |

Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda; Former Compliance Head, Rare Disease & Rare Blood Disorders, Sanofi, Boston, MA
|

Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant General Counsel, Pfizer, New York, NY |

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |

Christine Gordon, JD
CCO & Head of GRC; Governance, Risk & Compliance Function, Olympus; Former Assistant DA, Philadelphia DA's Office, Bethlehem, PA
|

Jaime Guerrero, JD
Vice President, Global Compliance, Edwards Lifesciences; Former AUSA, United States Attorneys' Office, Central District of California, Irvine, CA |

Neeraj Gupta, MBA
President & Chief Technology Officer, Cresen Solutions, Chester Springs, PA |

Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail Consulting Group; Former VP, Chief Privacy Officer, Celgene, Bridgton, ME
|

Kassie Harrold, JD
Executive Vice President, Chief Compliance Officer, Integrity & Compliance, Mallinckrodt; Former Global Compliance Counsel, Solutia, Hampton, NJ |

Becky Hayes, MPH, CCEP
Senior Compliance Officer, Training & Communications, Cencora; Former Group Compliance Officer, AmerisourceBergen, Fort Mill, SC |

Michael G. Hercz, JD
Senior VP & General Counsel, Sentyn; Former Executive Director, Enterprise Risk Management, Amgen, Los Angeles, CA
|

Howard Holloway
Global Governance Lead, Global Medical Affairs & Governance, Patient Oriented Programs, Novartis, Zurich, Switzerland |

Casey Horton
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL |

Amanda Johnston, JD, RAC
Managing Attorney, Gardner Law, PLLC; Adjunct Professor of Law, Mitchell Hamline School of Law, St. Paul, MN
|

Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC |

Melissa Kaschak, CPA, CFE, CISA
Compliance Operations, Olympus; Former Information Protection Officer, Penn Mutual, Allentown, PA |

Rim El Kassaby, LLM
Director US Business Counseling & Support, Organon, Dubai, UAE
|

Kiley Smith Kelly, MBA
Partner/Principal, Forensic & Integrity Services, EY, Philadelphia, PA |

Amy D. Kossak, JD
Partner, Ropes & Gray; Senior Trial Counsel, US Department of Justice, Washington, DC |

Lakshmi Krishnan
Lead, Monitoring & Risk Assessment, Takeda; Former Lead, Monitoring & Risk Assessment, Invidior, Boston, MA
|

Olivia Krzeminski, JD
Associate Director Compliance, G&M Health |

Angelique Lee, JD
VP, CCO & Ethics Officer, Jazz Pharmaceuticals; Former VP, Global CCO; R&D Legal Lead, Greenwich Biosciences, Orange County, CA |

Peter Lee, JD
Vice President Compliance, Mirati Therapeutics; Former CCO, Provention Bio & Heron Therapeutics, San Diego, CA
|

Terri L. Ledva, MS
Director, Ethics & Compliance, Aurobindo Pharma LTD; Former Senior Manager Compliance, Iroko Pharmaceuticals LLC, Philadelphia, PA |

Victoria A. Lipnic, JD
Partner, Head of Human Capital Strategy Group, Resolution Economics; Former Commissioner & Acting Chair, US EEOC, Washington, DC |

Cristina List, CPA, CCEP
Director, Compliance Advisory Services, MedPro Systems; Former Compliance Officer, Carestream, Mount Arlington, NJ
|

Kirsten Liston
Principal & Founder, Rethink Compliance; Co-author, The Compliance Entrepreneur's Handbook, Denver, CO |

Elaina McEwan
Director, Life Sciences Consulting Group, Litigation Department, Paul Hastings, New York, NY |

Gregory S. Moss, JD
Chief Corporate Strategy & Legal Officer, Evomunne; Former EVP, General Counsel & Corporate Secretary, CCO, Kadmon Holdings, Palo Alta, CA
|

Patrick Murphy, JD
SVP Global Head Litigation & Investigations, Fresenius Medical Care; Former General Counsel, Litigation, GE Healthcare, Washington, DC |

Daniel O'Connor
SVP, NXLevel Compliance; Former VP, Learning & Development, Morgan Stanley, New York, NY |

Adam Oakley
Senior Director, Potomac River Partners, Washington, DC
|

Kirk Ogrosky, JD
Partner and Co-Chair, Healthcare Government Enforcement, Goodwin Procter LLP; Deputy Chief, Fraud Section, Criminal Division, US DOJ, Washington, DC |

Gus Papandrikos, MBA
Global Head of Compliance Assurance, Daiichi Sankyo; Former Senior Head, Compliance Operations, Global Compliance & Risk Management, Shire, New York, NY |

Garrett Pape, JD
Senior Manager, Forensic & Integrity Services, EY, Chicago, IL
|

Danielle Pelot, JD
Partner, Choate Hall & Stewart, Boston, MA |

Kristen Perriello, JD
Principal, Choate, Hall & Stewart, LLP; Former Special Assistant District Attorney, Suffolk County District Attorney's Office, Boston, MA |

Saraswatha Putcha, MA
Associate Director, Global Risk Assessment & Monitoring, Cresen Solutions, Philadelphia, PA
|

John S. Rah, JD
Counsel, Potter & Murdock, Potomac, MD |

David Ralston, JD
Managed Care Attorney Consultant; Market Access Legal Specialist, Biogen and Rocket Pharmaceuticals, Boston, MA |

Nikki Reeves, JD
Partner & Co-chair, Life Sciences & Healthcare Industry Group, King & Spalding, Washington, DC
|

Timothy Roberts, MA
Global Chief Compliance Officer, Legend Biotech; Former US Compliance & Privacy Officer, Ferring, Mendham, NJ |

Tad Roselund
Managing Director & Senior Partner and Former Chief Risk Officer, The Boston Consulting Group, Montclair, NJ |

Elan Schefflein, JD
Senior Compliance Advisor, MedPro Systems; Assistant District Attorney; Nassau County District Attorney, New York, NY
|

Sulin Shah, JD
Law Offices of Sulin Shah; Legal Consultant, Soleno Therapeutics; Former VP, US General Counsel, PharmaEssentia & Orphazyme A/S, Chicago, IL |

Alexis Shaw
Deputy Chief Compliance Officer, Paratek; Former Compliance Officer, Endo, Malvern, PA |

Michael L. Shaw, JD
Global Head of Compliance, Privacy & Risk, ZS; Former VP & Compliance Officer, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ
|

Paul Silver
Corporate Intelligence Services Practice Leader, Life Sciences Regulatory, Legal, & Compliance Leader, Deloitte Advisory, Atlanta, GA |

Sara R. Simon, JD
Counsel, Porzio, Bromberg & Newman; Former Director, US Health Care Compliance Certification Program, Seton Hall University School of Law, Morristown, NJ |

Laura A. Skinner, MBA
Managing Director, Life Sciences Consulting Group, Paul Hastings, New York, NY
|

Mike Stanek, JD
Associate Vice President, Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN |

Natasha Trifun, JD
Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions, Alexion, AstraZeneca Rare Disease, Boston, MA |

L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former SVP and CCO, Warner Chilcot; Former VP, Ethics and Compliance Officer, TAP Pharmaceutical, Boston, MA
|

Tyler Wiseman, MBA, JD
Chief Legal Officer, Elevar Therapeutics; Former Corporate Counsel, Praxis Precision Medicines, Boston, MA |

Ronald L. Wisor, Jr, JD
Partner, Lifesciences & Healthcare, Hogan Lovells, Washington, DC
|
|
|
|
|
PRESENTATION PROPOSALS
|
Click here to submit a presentation proposal.
|
SPONSORED BY
|
|
PRODUCED BY
|
|
PCF BOARD
|

Donna White, CCEP
Vice President and Compliance Officer, Chiesi (Board Chair)

Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed (Board Secretary)

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte (Board Treasurer)

Cindy Cetani, LPEC, NACD.DC®
Chief Integrity and Compliance Officer, Indivior

Anisa Dhalla
Vice President and Chief Ethics and Compliance Officer, UCB

Daryl Kreml, JD
Senior Vice President, Chief Enterprise Risk and Compliance Officer, Sage Therapeutics
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|

Michael R. Clarke, JD, CCEP
VP, Global CCO, ConvaTec

Sujata Dayal, JD
Independent Board Director, Emergent; BioSolutions; Senior Advisor, Ethicist International

Tara Shewchuk, JD
Global Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
GRANTORS
|
PLATINUM
|

|
GOLD
|








|
SILVER
|











|
BRONZE
|


















|
MEDIA PARTNERS
|



|
PENDING CONTINUING EDUCATION CREDITS
|
Compliance Certification Board (CCB)®.

Continuing Legal Education

Certificates of Attendance.
Attendees may download and self-complete a certificate of attendance which will be posted on the Congress virtual video broadcast platform to file with appropriate certifying bodies which accept such.
|
TUITION SCHOLARSHIPS
|
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.
Click here for more information.
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
For sponsorship and exhibit information contact Sarah Grosse, Exhibit & Sponsorship Coordinator, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|